Join
Live feed
·
INSIDERFilingvia Quantisnow
Tonix Pharmaceuticals Holding Corp. logo

Chief Executive Officer Lederman Seth disposed of $18 worth of shares (6 units at $2.87), decreasing direct ownership by 51% to 5 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TNXP· Tonix Pharmaceuticals Holding Corp.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNXP (Tonix Pharmaceuticals Holding Corp.) and more on Quantisnow.